December 15, 2025 · Form 4 insider transaction
Barnes Alane P sold 21,210 shares of BioCryst Pharmaceuticals, Inc. at $7.65 per share, a transaction worth $162.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.